BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 9121985)

  • 1. The value of DDD pacing in patients with an implantable cardioverter defibrillator.
    Geelen P; Lorga Filho A; Chauvin M; Wellens F; Brugada P
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):177-81. PubMed ID: 9121985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dual-chamber implantable automatic defibrillators. Experiences apropos of 16 cases].
    Le Franc P; Klug D; Lacroix D; Kouakam C; Jarwé M; Kacet S
    Arch Mal Coeur Vaiss; 1998 Jun; 91(6):739-44. PubMed ID: 9749190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
    JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing.
    Hesselson AB; Parsonnet V; Bernstein AD; Bonavita GJ
    J Am Coll Cardiol; 1992 Jun; 19(7):1542-9. PubMed ID: 1593051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurements of cardiac output by impedance cardiography in pacemaker patients at rest: effects of various atrioventricular delays.
    Ovsyshcher I; Zimlichman R; Katz A; Bondy C; Furman S
    J Am Coll Cardiol; 1993 Mar; 21(3):761-7. PubMed ID: 8436759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for dual-chamber (DDD) pacing in implantable cardioverter-defibrillator patients.
    Santini M; Ansalone G; Auriti A; Magris B; Pandozi C; Altamura G
    Am J Cardiol; 1996 Sep; 78(5A):116-8. PubMed ID: 8820847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAIsafeR limits ventricular pacing in unselected patients.
    Pioger G; Leny G; Nitzsché R; Ripart A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S66-70. PubMed ID: 17302721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study.
    Botto GL; Ricci RP; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Garutti C; Vainer L; Kozák M;
    Heart Rhythm; 2014 Jun; 11(6):992-1000. PubMed ID: 24418164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Support of spontaneous atrioventricular conduction in patients with DDR(R) pacemakers: effectiveness and safety].
    Himmrich E; Krämer LI; Fischer W; Dörr T; Reinecke H;
    Herz; 2001 Feb; 26(1):69-74. PubMed ID: 11258112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of automatic mode change between DDD and AAI to facilitate native atrioventricular conduction in patients with sick sinus syndrome or transient atrioventricular block.
    Mayumi H; Kohno H; Yasui H; Kawachi Y; Tokunaga K
    Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1740-7. PubMed ID: 8945033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale.
    Pastore G; Bertini M; Bonanno C; Coluccia G; Dell'Era G; De Mattia L; Grieco D; Katsouras G; Maines M; Marcantoni L; Marinaccio L; Paglino G; Palmisano P; Ziacchi M; Zoppo F; Noventa F
    Europace; 2023 May; 25(5):. PubMed ID: 36974970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of heart rate response during exercise in patients using atrioventricular synchronous and ventricular pacemakers.
    McMeekin JD; Lautner D; Hanson S; Gulamhusein SS
    Pacing Clin Electrophysiol; 1990 Jan; 13(1):59-68. PubMed ID: 1689036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary clinical experience with the first dual chamber pacemaker defibrillator.
    Lavergne T; Daubert JC; Chauvin M; Dolla E; Kacet S; Leenhardt A; Mabo P; Ritter P; Sadoul N; Saoudi N; Henry C; Nitzsche R; Ripart A; Murgatroyd F
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):182-8. PubMed ID: 9121986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictors for need of antibradycardia and antitachycardia pacing after ICD implantation : Implications for the subcutaneous ICD].
    Grett M; Christ M; Trappe HJ
    Herzschrittmacherther Elektrophysiol; 2016 Dec; 27(4):390-395. PubMed ID: 27738753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doppler ultrasound measurement of cardiac output in patients with physiologic pacemakers. Effects of left ventricular function and retrograde ventriculoatrial conduction.
    Stewart WJ; Dicola VC; Harthorne JW; Gillam LD; Weyman AE
    Am J Cardiol; 1984 Aug; 54(3):308-12. PubMed ID: 6465010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near elimination of ventricular pacing in SafeR mode compared to DDD modes: a randomized study of 422 patients.
    Davy JM; Hoffmann E; Frey A; Jocham K; Rossi S; Dupuis JM; Frabetti L; Ducloux P; Prades E; Jauvert G
    Pacing Clin Electrophysiol; 2012 Apr; 35(4):392-402. PubMed ID: 22309303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of Need for Antitachycardia or Antibradycardia Pacing or Cardiac Resynchronization Therapy in Patients With a Single-Chamber Implantable Cardioverter-Defibrillator.
    Melles MC; Yap SC; Bhagwandien RE; Sakhi R; Szili-Torok T; Theuns DAMJ
    Am J Cardiol; 2018 Dec; 122(12):2068-2074. PubMed ID: 30340766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.